Dr Reddy's Launches Dutas For Enlarged Prostrate

OUR CORPORATE BUREAU

HYDERABAD, APRIL 19: In yet other initiative, Dr Reddy's Laboratories has launched Dutas for treatment of enlarged prostrate in India. The generic name of Dutas is dutasteride and Dr Reddy's becomes the first company to launch this drug in India.
Symptomatic enlarged prostrate affects about 55 per cent of men over the age of 50 and almost 90 per cent over the age worldwide. In India, there are over 77 million men over the age of 60 who are affected by this disease. It is a progressive disease with obstructive urinary symptoms that worsen with age.
Until 10 years ago, surgery was the only treatment for this ailment. The medical management of symptomatic enlarged prostrate is well-established and offers the convenience of oral treatment as opposed to surgery.
Commenting on the launch, Mr Jaspal Singh Bajwa, president of the branded formulation business, said, Dr Reddy's was the first company to introduce medical management of symptomatic enlarged prostrate in the country with the launch of its brand Finast (generic name: finasteride) in 1996.
Dutasteride addresses the medical need of not only managing the symptoms but also helps in arresting disease progression, the release added.